Page last updated: 2024-10-21

3-methoxytyramine and Deficiency, Mental

3-methoxytyramine has been researched along with Deficiency, Mental in 2 studies

3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.

Research Excerpts

ExcerptRelevanceReference
"The Fragile X syndrome, a common form of mental retardation in humans, is caused by silencing the fragile X mental retardation (FMR1) gene leading to the absence of the encoded fragile X mental retardation protein 1 (FMRP)."1.31Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome. ( Braun, K; Gruss, M, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gruss, M1
Braun, K1
Martineau, J1
Barthélémy, C1
Jouve, J1
Muh, JP1
Lelord, G1

Other Studies

2 other studies available for 3-methoxytyramine and Deficiency, Mental

ArticleYear
Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome.
    Neural plasticity, 2001, Volume: 8, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Alanine; Amino Acids; Animals; Aspartic Acid; Brain; Brain St

2001
Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects.
    Developmental medicine and child neurology, 1992, Volume: 34, Issue:7

    Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Autistic Disorder; Catecholamines; Child; Child Develop

1992
chemdatabank.com